UCARS-3.19.21 Impact of Recent Advances & Discoveries Myocardial Recovery
From u0667272 on March 23rd, 2021
You are responsible for the videos uploaded to the Health Care instance of Media Space, This instance is meant to be a public library of videos. Content should not contain PHI or private information.
Chairs: Kirk Knowlton, MD (Intermountain Healthcare) and James C. Fang, MD (U of Utah)
- Muscle biology leading to novel biomarker and therapy: Cardiac bridging integrator 1 (cBIN1) Robin Shaw, MD, PhD, U of Utah/CVRTI
- Impact of new HF meds (SGLT2i, vericiquat and omecamtiv) on (a) cardiac remodeling and (b) patient outcomes. Gerasimos Filippatos, MD, U of Athens, Greece
- Relapse after recovery from HFrEF: risk factors, pharmacological interventions and CRT. John Cleland, MD, University of Glasgow, Scotland, UK
- Using exercise hemodynamics for recovery assessment in patients with LVAD. Van-Khue Ton, MD, PhD, MGH/Harvard